Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Præsentation
Citationsformater

Rune Nielsen
Hannu Kankaanranta
Leif Bjermer
Lange, Peter
Sofie Arnetorp
Morten Hedegaard
Anna Stenling
Nicole Mittmann

Assess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler(®)+tiotropium (TIO) HandiHaler(®) vs. placebo (PBO)+TIO in patients with chronic obstructive pulmonary disease (COPD) eligible for inhaled corticosteroids/long-acting β2-agonists (ICS/LABA).

Originalsprog	Engelsk
Tidsskrift	Respiratory Medicine
Vol/bind	107
Udgave nummer	11
Sider (fra-til)	1709-21
Antal sider	13
ISSN	0954-6111
DOI	https://doi.org/10.1016/j.rmed.2013.06.007
Status	Udgivet - nov. 2013

ID: 105585066